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Abstract: 
Introduction: The objective of the present study to compare immunomodulatory activity of Marketed Ayurvedic 
Formulation viz Formulation I and Formulation II. 
Material and Method: In the present study the dose selection of Formulation I and Formulation II for the particular 
species (Rat) were selected on the basis of the method described by Paget and Barnes.  The assessments of 
immunomodulatory activity were carried out by using Delayed Type Hypersensitivity Test, Carbon Clearance Test 
and Neutrophil adhesion test. 
Result: Oral administration of Marketed Formulation I and Formulation II significantly (P<0.0001) showed 
Immunomodulatory activity by increase in DTH response, phagocytic activity, and Neutrophil adhesion in Rat at 
experimental dose.  
Conclusion: The study demonstrated that both the Formulation I and Formulation II shows significant 
immunomodulatory effect on both humoral as well as cell mediated immunity. While among two Formulation II 
showed more immunomodulatory activity as compare with Formulation I. Present study it was revealed that 
Formulation II showed more immunomodulatory activity than Formulation I due to presence of multiple 
immunomodulatory ingredient in its Formulation (Tinospora Cardifolia , Ocimum Sactum , Glycyrrhiza Glabra , 
Aconitum hetrophylum ,Cyperus rotundus , Pistacia integerrimg), when compare with Formulation I it contain 
single ingredient ( Tinospora Cardifolia). Ocimum Sactum which is present in Formulation II is a more potent 
immunomodulator than Tinospora Cardiofolia. 
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INTRODUCTION: 
Human system is under constant threat from a variety 
of pathogenic organisms (bacteria, viruses, fungi, 
protozoa etc.), parasite and tumour cells. Even 
nonliving substance such as organic, inorganic 
molecules, pollutants in the atmosphere poisons and 
toxins etc. are also cause a potential threat. The 
immune system is remarkably versatile system that 
has evolved to defense itself against this vast range of 
harmful agents. It is able to generate an enormous 
variety of cell and molecules capable of specifically 
recognizing and eliminating variety of foreign 
invaders. Immune activation is a protective as well as 
effective approach against emerging infectious 
disease. Immunostimulation constituent either an 
alternative to or an adjuvant for conventional 
chemotherapy and prophylaxis of infection, for tumor 
as well as autoimmune diseases, especially when the 
host immune system is impaired. [1] 
Immunomodulators are natural or synthetic substance 
that help to regulate or normalize the immune system. 
Immunomodulators correct immune systems that are 
out of balance. Immunomodulators are recommended 
for individuals with autoimmune diseases and they 
are widely used in chronic illness to restore immune 
system, and in individuals who have been on lengthy 
course of antibiotics or antiviral therapies. [2]  
 
The suppression of the immune system associated 
with tuberculosis (TB), cancer, surgery or HIV 
infection is characterized by a reduction in the 
number and phagocytic function of neutrophils and 
macrophages as well as a reduction in the 
intracellular bactericidal capacity of these cells. This 
profound suppression of the individual elements of 
the system allows opportunistic pathogens to 
overwhelm the host so that secondary infection 
becomes the most common cause of the mortality in 
such individuals. 
 
The Concept of Immunostimulation in Ayurveda has 
been used successfully in the treatment of 
immunocompromised condition like AIDS, 
Tuberculosis, cancer and hepatic disease. One of the 
main strategies in ayurvedic medication is to increase 
body’s natural resistance to disease causing agent 
rather than directly neutralizing the agent itself. In 
practice this achieved by using extracts of various 
plant material called “Rasayanas”, a group of non-
toxic herbal drug preparation which are used to 
improve the general health by stimulation of body’s 
immunity.[3,4,5,] 
 
In the light of above we considered it appropriate to 
screen some immunomodulators Ayurvedic 
Formulation sold in the Indian market for animals 
(preclinical) studies. Thus present work is undertaken 
to investigate and compare the immunomodulatory 
properties of two herbal Formulation viz. 
Formulation I and Formulation II. 
 
MATERIALS AND METHODS: 
Animals: All the experimental were carried out using 
male albino rat of Wistar strain. Weight around 150-
200 gm. The animals are free access of food and 
water, and they were housed in a natural (12 h each) 
light -dark cycle. The animals were acclimatized for 
at least 5 day to the laboratory conditions before the 
experiment. The experimental protocol was approved 
by the institutional animal ethics committee 
(IAEC/ABCP/01/2016-17) and the care of laboratory 
animal was taken as per the guideline of CPCSEA. 
Drugs and Chemicals: All the drugs and Chemical 
were of analytical grade while the other drugs were 
procured - Levamisole (Johnson & Johnson Ltd.), 
colloidal carbon (Indian Ink, camel India Pvt. Ltd.) 
Formulation I &Formulation II (Indian Market) 
Selection of doses: In the present study the dose 
selection of Formulation I and Formulation II for the 
particular species (Rat) were selected on the basis of 
the method described by Paget and Barnes. The 
method is based on body surface area of various 
species and a dose for one strain can be calculated 
with the help of another strain whose dose is 
previously known. The doses of the drugs were 
calculated by extrapolating the therapeutic dose to rat 
dose on the basis of body surface area ratio 
(conversion factor 0.018 for rats) [6] 
Conversion factor for rat: 
 Humans dose x 0.018 = X g/200g.Of  rat. 
X x 5=Y g/kg of rat. 
 
PHARMACOLOGICAL SCREENING 
The immunomodulatory activity is carried out using 
the following in-vivo immunomodulatory models. 
1. Delayed Type Hypersensitivity Reaction. 
2. Carbon Clearance Test. (Test for Phagocytosis). 
3. Neutrophil Adhesion Test. 
 
1. DELAYED TYPE HYPERSENSITIVITY 
REACTION: (21 Days Model) 
Purpose and Rationale: 
Delayed hypersensitivity reaction is a reaction of cell 
mediated immunity and become visible only after 16-
24 hrs. 
 Procedure: 
1. In this test animals were divided into four group 
comprising 6 animals in each.   
2. Group I was kept as a control and received 
vehicle only (water) 10 ml/kg. 
3. Group II was kept as a standard and received 
standard drug levamisole (50 mg/kg). 
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4. Group III was kept as test I and received the 
ayurvedic Formulation I. 
5. Group IV was kept as test II and received the 
ayurvedic Formulation II. 
Table 1:  Grouping and Treatment Schedule for 
DTH Test 
 
6. Immunized Rat with 0.1ml of 20% SRBCS in 
normal saline intraperitonially on 14th                               
day of the study. On day 21st, animals from all 
groups get challenge with 0.03ml of 1% SRBCs in 
sub plantar region of right hind paw. Foot pad 
reaction was assessed after 24hrs i.e. on 22nd day. 
Increase in foot pad edema was measured with the 
help of vernier caliper or by using Plethysmometer. 
[7,8]  
Antigenic material: 
Preparation of sheep RBCs: Sheep blood was 
collected in sterile Alsever’s solution in 1:1 
proportion, Alsever’s solution (freshly 
prepared).blood was kept in the refrigerator and 
processed for the preparation of SRBCs batch, by 
centifugating at 2000 rpm for 10min and washing 
with physiological saline 4-5 times and then 
suspending into buffered saline for further use.[9]   
Composition of Alsever’s Solution 
 
Table 2: Composition of Alsever’s Solution 
Chemicals Quantity(g/L) 
Sodium Chloride 4.2 
Sodium Citrate 8.0 
Citric acid anhydrous  0.55 
Glucose 20.5 
Distilled water q.s. 1000ml 
 
Statistical analysis:  Result was expressed as mean 
value ± SEM. The variation in a set of data has been 
estimated by performing one way analysis of 
variation (ANOVA). Individual comparison of group 
mean value were done using Dunnets test.  P 
value<0.05, were considered statistically significant.  
2. CARBON CLEARANCE TEST: (10 Days 
Model)  
Purpose and Rationale: Phagocytic activity of 
reticuloendothelial system was assay by carbon 
clearance test; phagocytic index was calculated as a 
rate of carbon elimination of reticuloendothelial 
system by carbon clearance test. 
 Procedure: 
1. In this test Animals were divided into four 
group comprising 6 animals in each.   
2. Group I was kept as a control and received 
vehicle only (water) 10 ml/kg. 
3. Group II was kept as a standard and received 
standard drug Levamisole (50 mg/kg). 
4. Group III was kept as test I and received the 
ayurvedic Formulation I. 
5.  Group IV was kept as test II and received the 
ayurvedic Formulation II. 
Table 3: Grouping and Treatment Schedule 
for Carbon Clearance Test 
 
 
6. Carbon ink suspension was injected via tail vein 
to each rat 48 hours after the              five day 
treatment  
7. Blood sample (25 μl) were then withdrawn 
from the retro-orbital plexus under mild ether 
anesthesia at 5 and 15 min after injection of 
colloidal carbon ink lysed in 0.1% sodium 
carbonate solution (3 ml). 
8. The optical density was measured 
spectrophotometrically at 660 nm. 
9. The phagocytic activity was calculated using 
the following formula. [7,8] 
 
 
 
 
        
 Where ODI and OD2 are the optical densities at time 
t1 and t2, respectively. 
 
 
 
Sr. 
No 
Group Test Substance Dose 
1 Group I Control  ( water) 10 ml/kg 
2 Group II Std ( Levamisole) 50 mg/kg  
3 Group III Formulation I  0.54 ml 
twice a 
day 
4 Group IV Formulation II   0.54 ml 
twice a 
day 
Sr. 
No 
Group Test Substance Dose 
1 Group I Control  ( water) 10 ml/kg 
2 Group II Std ( Levamisole) 50 mg/kg  
3 Group III Formulation I  0.54 ml 
twice a day  
4 Group IV Formulation II  0.54 ml 
twice a day 
K= Log OD1-Log OD2 
t2 – t1 
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Preparation of carbon ink suspension:  Camlin ink 
was diluted eight times with saline and used for 
carbon clearance test in a dose of 10 μl/gm body 
weight of rat.[9] 
Statistical analysis: Result was expressed as mean 
value ± SEM. The variation in a set of data has been 
estimated by performing one way analysis of 
variation (ANOVA). Individual comparison of group 
mean value were done using Dunnets test.  P 
value<0.05, were considered statistically significant. 
3. NEUTROPHILE ADAHESION TEST (16 days 
Model) 
Purpose and Rationale: Increase the recruitment of 
neutrophils adhesion to nylon fibers which correlates 
to the process of margination of cells in blood 
vessels. 
Procedure: 
1. In this test animals were divided into four group 
comprising 6 animals in each.   
2. Group I was kept as a control and received 
vehicle only (water) 10 ml/kg. 
3. Group II was kept as a standard and received 
standard drug Levamisole (50 mg/kg). 
4. Group III was kept as test I and received the 
ayurvedic Formulation I. 
5.  Group IV was kept as test II and received the 
ayurvedic Formulation II 
Table 4: Grouping and Treatment Schedule for 
Neutrophil adhesion Test 
 
6.  On 16th day of the treatment, blood sample from 
all the group were    collected by puncturing retro-
orbital plexus under mild ether anesthesia. 
7.  Blood was collected in vials pre-treated by 
disodium EDTA and analyzed for total leukocyte 
count (TLC) and differential leukocyte count (DLC). 
8.  After initial count blood sample were collected 
with nylon fiber (80 mg/ml,   previously sterilized by 
95% alcohol) for 15min at 370C.the incubated drug 
sample were analyzed for TLC and DLC. 
9.  The product of TLC and % neutrophils adhesion 
was calculated as follows.[7,8] 
 
 
 
 
 
 
 
Where, 
NIU: Neutrophil index before incubation with nylon 
fibers. 
NIT:  Neutrophil index after incubation with nylon 
fibers. 
Statistical analysis: Result was expressed as mean 
value ± SEM. The variation in a set of data has been 
estimated by performing one way analysis of 
variation (ANOVA). Individual comparison of group 
mean value were done using Dunnets test.  P 
value<0.05, were considered statistically significant.  
 
RESULT: 
Delayed Type of Hypersensitivity Reaction: Effects 
of Formulation I and Formulation II on cell mediated 
immune response by DTH induce footpad edema is 
shown in [Table:5] Formulation I and Formulation II 
treated group significantly showed increase in 
footpad edema (P<0.0001) when compare with 
control group. Formulation I showed increase in 
footpad edema 3.893±0.01 which potentiate DTH 
response to 144.07 % when compare with control. 
Similarly Formulation II showed increase in footpad 
edema 4.495±0.01 which indicate increase in DTH 
response up to (166.3 %) when compare with control. 
 
Table 5: Result of DTH 
 
Sr. No Group Treatments and route of 
Administration 
Mean difference in paw edema in 
(mm) (Mean±SEM) 
1 I Control (P.O.) 2.702±0.01   (100 %) 
2 II Standard (Levamisole) (P.O.) 4.192±0.01**** (↑155.1 %) 
3 III Formulation I (P.O.) 3.893±0.01**** (↑144.07 %) 
4 IV Formulation II (P.O.) 4.495±0.01**** (↑166.3 %) 
Values are expressed as (Mean ±S.E.M). n=6 ****P<0.0001 statistically significant when compared with control group by 
ANOVA followed by Dunnett test.
.  
S. No Group Test Substance Dose 
1 Group I Control  ( water) 10 ml/kg 
2 Group II Std ( Levamisole) 50 mg/kg  
3 Group III Formulation I  0.54 ml 
twice a day  
4 Group IV Formulation II  0.54 ml 
twice a day 
                                                 NIU 
Neutrophil adhesion (%) = NIU –NIT  X 100 
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Fig.1:  Graphical representation of DTH 
Carbon Clearance Test: Effect of Formulation I and 
Formulation II on the phagocytic activity by carbon 
clearance test is shown in [Table: 6].The phagocytic 
activity of reticuloendothelial system is generally 
measured by the rate of removal of carbon particle 
from the blood stream. In carbon clearance test 
Formulation I & Formulation II treated all group 
exhibited significantly high phagocytic index 
(P<0.0001) when compare with control group. 
Formulation I treated group showed phagocytic index 
0.05562±0.0009 which indicated stimulation of 
reticuloendothelial system to 164.70 % when 
compare with control. Similarly Formulation II 
treated group showed phagocytic index 
0.06335±0.0008 which potentiate reticuloendothelial 
system to 187.59 % when compare with control 
group. 
 
Table 6: Result of Carbon Clearance Test. 
Sr. 
No 
Group Treatments 
Dose and route of 
administration 
Absorbance Phagocytic index 
(Mean±SEM) 5 min 15 min 
1 I Control 10 ml/kg (P.O.) 0.169 0.078 
0.03377±0.0009 
(100 %) 
2 II 
Standard 
(Levamisole) 
50 mg/kg (P.O.) 0.154 0.041 
0.05815±0.0001**** 
(↑172.55 %) 
3 III Formulation I 
0.54 ml twice a day 
(P.O.) 
0.162 0.045 
0.05562±0.0009**** 
(↑164.70 %) 
4 IV Formulation II 
0.54 ml twice a day 
(P.O.) 
0.152 0.035 
0.06335±0.0008**** 
(↑187.59%) 
 
Value are expressed as (Mean ±SEM).n=6 ****P<0.0001 statistically significant when compared with 
control group by ANOVA followed by Dunnett test. 
 
Graph: 2. Graphical representation of Carbon Clearance Test 
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Table: 7. Result of Neutrophil Adhesion test. 
 
 
 
 
 
 
 
Values are expressed as (Mean ±S.E.M).n=4 ****P<0.0001 Statistically significant when compared with control 
group by ANOVA followed by Dunnett test. 
 
Fig: 3. Graphical representation of Neutrophil Adhesion Test. 
 
Result Of Neutrophil Adhesion Test: Effect of 
Formulation I and Formulation II on neutrophils 
activation by the neutrophils adhesion test is shown 
in [Table: 7] Cytokines are secreted by activated 
immune cell for margination and extravasations of 
the phagocytes mainly Polymorphonuclear 
neutrophils. The percentage neutrophils adhesion was 
significantly (P<0.0001) increase by Formulation I 
(63.83 %) and Formulation II (74.47 %) when 
compare with control group showed possible 
Immunostimulant effect. Formulation I and 
Formulation II significantly evoked increase in the 
adhesion of neutrophils to nylon fibers which 
correlates to the process of margination of cell in 
blood vessels. 
 
DISCUSSION: 
Immunomodulation is a process which can alter 
immune system, specifically stimulation or 
suppression and thus immunomodulators are immune 
stimulant and immune suppressant. Modulation of 
immune responses to alleviate the diseases has been 
interest for many years, and immunostimulation and 
immunosuppressant both needed to be tackle in order 
to regulate the normal immunological function. [7] A 
number of medicinal plants of rasayanas have been 
claimed to possess immunomodulatory activity and 
many Formulation of these plant products are 
available to enhance the immune system. Hence 
present study was carried out to estimate the 
immunomodulatory activity of marketed Formulation 
viz Formulation I and Formulation II. Thus present 
study was design   to explore and compare the 
possible immunomodulatory activity of Formulation I 
and Formulation II. 
 
In the present study carbon clearance test, Delayed 
type of hypersensitivity test, Neutrophils adhesion 
test and chronic administration of test Formulation 
were selected for evaluation of immunomodulatory 
effect of Ayurvedic Formulation I and Formulation 
II. 
 
According to Sites DP et al. Delayed hypersensitivity 
test is part of the process of the graft rejection, tumor 
immunity, and most important, immunity against 
many intracellular infectious microorganisms, 
specially those causing chronic disease such as 
tuberculosis. Delayed hypersensitivity test required 
the specific recognization of antigen to activate T 
lymphocytes which substantially proliferate and 
release the cytokines, which in turn increase vascular 
permeability; induce vasodilatation, macrophage 
accumulation and activation promoting increase 
phagocytic activity and increase concentration of 
lytic enzyme for more effective killing. In the present 
study SRBCs, served as a sensitizer substance which 
in combination with skin protein produces 
antigenicity, and generate hypersensitivity reaction in 
rat. [10] In present research work it was found that 
Formulation I , Formulation II and levamisole  causes 
increase in the footpad edema after 24 hrs of the 
exposure to SRBC 3.893±0.01mm (144.07 %) , 
4.495±0.01mm (166.3 %)  and 4.192±0.01 (155.1 %) 
Sr. no Group %Neutrophil  Adhesion 
1 Control 29.55±0.6919  
2 Standard 69.24±0.5614**** 
3 Formulation I 63.83±0.8031**** 
4 Formulation II 74.47±0.7064**** 
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respectively. when compared with control 2.070 ± 
0.01mm (100 %) . This indicated stimulation of cell 
mediated immunity.    
 
According to Smriti Tripathi et al. Phagocytic 
activity of reticuloendothelial system was assayed by 
carbon clearance test. Phagocytic index was 
calculated as rate of carbon elimination of 
reticuloendothelial system by carbon clearance test. 
[11] In the present work, phagocytic index of 
Formulation I was 0.05562± 0.0009 (164.70 %) 
Formulation II showed 0.06335±0.0008 (187.59 %) 
and Levamisole 0.05815±0.0001 (172.55 %) when 
compare with vehicle control 0.03377±0.0009. This 
revealed that Formulation II have highest phagocytic 
index than Formulation I and Levamisole. Thus 
increase in phagocytic activity indicated that there 
was stimulation of reticuloendothelial system. 
 
According to Roitt I et al. Movement of neutrophils 
towards the foreign body is the first and most 
important step in phagocytosis process. Cytokines are 
secreted by activated immune cell for margination 
and extravasations of phagocytes mainly 
Polymorphonuclear neutrophils. Experimentally 
activation of the neutrophils can be study by 
neutrophils adhesion test. Our result showed that 
Formulation I , Formulation II and Levamisole were 
found to be stimulate neutrophils chemotaxis and 
increase % of neutrophils adhesion when compare 
with the control group. Further it was observed that 
Formulation II showed highest % of neutrophils 
adhesion (74.47±0.7064%) than Formulation I 
(63.83±0.8031%) and Levamisole (69.24±0.5614%) 
when compared with vehicle control 
(29.55±0.6911%).   
 
In the present study it was revealed that Formulation 
II showed more immunomodulatory activity than 
Formulation I due to presence of multiple 
immunomodulatory ingredient in its Formulation 
(Tinospora Cardifolia , Ocimum Sactum , 
Glycyrrhiza Glabra , Aconitum hetrophylum 
,Cyperus rotundus , Pistacia integerrimg), when 
compare with Formulation I it contain single 
ingredient ( Tinospora Cardifolia). Ocimum Sactum 
which is present in Formulation II is a more potent 
immunomodulator than Tinospora Cardiofolia. 
In this study, the overall order of immunomodulatory 
activity was established as Formulation II > 
levamisole > Formulation I 
 
CONCLUSION:  
The present study demonstrates that Formulation I 
and Formulation II shows significant 
Immunomodulatory effect on both humoral as well as 
cell mediated immunity which is due to 
 Increase the Polymorphonuclear neutrophils and 
their activation leading to margination in the 
blood vessels. 
 By the activation of reticuloendothelial system. 
 Enhance capacity of monocytes Macrophages 
system. 
Further among the two Formulation, Formulation II 
shows more immunomodulatory activity than 
Formulation I and, the overall order of 
immunomodulatory activity is   Formulation II > 
levamisole > Formulation I.  
 
ACKNOWLEDGEMENTS: 
The authors thank to Appasahen Birnale College of 
Pharmacy, Sangli, Maharashtra for providing lab 
facilities. 
 
REFERENCES: 
1.Papiya Mitra Mazumder;et al., Evaluation of 
immunomodulatory activity of Glycyrhiza glabra L 
roots in combination with zing. Asian pacific journal 
of tropical biomedicine,2012;S15-S20. 
2.U.S. Patil; et al., Immunomodulators: A 
Pharmacological Review. International Journal of 
Pharmacy and Pharmaceutical Sciences.2012; 4. 
3.Thatte; et al., Ayurveda and contempary scientific 
thought. Trends in Pharmacological 
Sciences.1986;7:247-249. 
4.Devasgayam; et al., Immune system and 
antioxidants, especially those derived from Indian 
medicinal Plants. Indian Journal of Experimental 
Biology.2002;40: 639-655. 
5.Hazzard, W. R. The Biology o f Ageing.1983;418-
422. 
6.Ghosh MN; (1981) Fundamental of Experimental 
Pharmacology. Calcutta Scientific Book Agency. 
p.192-3 
7.Tripathi S; et al., Immunomodulatory property of 
ethanolic extract of Trigonella foenum-graeceum 
leaves on mice. Scholar Research Library. 
2012;s4(2):708-713. 
8.Sharma A, Rangari V. Immunomodulatory activity 
of methanol extract of Adansonia digitata L .Trop J 
Pharm Res.2016;15(9):1923-1927. 
9.Dashputre N.L, Naikwade N.S.Immunomodulatory 
activity of Abutilon indicum Linn. On Albino Mice. 
IJPSR. 2010;1(3):178-184. 
10.Roitt I, Brostoff J, Male D. In: Immunology 3rd Ed 
London Mosby1993,1:7. 
11.Sites DP, Terr AI, Parbeco GT. Medical 
immunology.2004;9:376-388. 
 
 
